Open AccessSustained Dorzolamide Release Prevents Axonal and Retinal Ganglion Cell Loss in a Rat Model of IOP–Glaucoma
Author(s) -
Ian Pitha,
Elizabeth Kimball,
Ericka Oglesby,
Mary Ellen Pease,
Jie Fu,
Julie Schaub,
Yoo-Chun Kim,
Qi Hu,
Justin Hanes,
Harry A. Quigley
Publication year - 2018
Publication title -
translational vision science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 21
ISSN - 2164-2591
DOI - 10.1167/tvst.7.2.13
Subject(s) - dorzolamide , ophthalmology , glaucoma , retinal ganglion cell , medicine , retinal , optic nerve , ocular hypertension , retina , biology , timolol , neuroscience
Sustained release IOP-lowering medications have the potential to stop glaucoma progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom